Sofer, Y., Nash, Y., Osher, E., Fursht, O., Goldsmith, G., Nahary, L., . . . Frenkel, D. (2021). Insulin-degrading enzyme higher in subjects with metabolic syndrome. Endocrine, 71(2), 357-364. https://doi.org/10.1007/s12020-020-02548-2
Citace podle Chicago (17th ed.)Sofer, Y., et al. "Insulin-degrading Enzyme Higher in Subjects with Metabolic Syndrome." Endocrine 71, no. 2 (2021): 357-364. https://doi.org/10.1007/s12020-020-02548-2.
Citace podle MLA (9th ed.)Sofer, Y., et al. "Insulin-degrading Enzyme Higher in Subjects with Metabolic Syndrome." Endocrine, vol. 71, no. 2, 2021, pp. 357-364, https://doi.org/10.1007/s12020-020-02548-2.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..